Cosmos Health (COSM) Director Suhel Bhutawala Receives 20,000-Share Award

What Happened Suhel Bhutawala, a director of Cosmos Health Inc. (COSM), was granted 20,000 shares of common stock via RSUs on May 19, 2026. The grant was reported at $0.28 per share, a total reported value of $5,660. The filing also shows a corresponding conversion of a derivative security for 20,000 shares (reflecting the RSUs converting into common stock) with no cash proceeds.

Key Details

• Transaction dates: May 19, 2026 (grant and conversion).
• Report filed: June 11, 2026 (the filing is later than the typical 2-business-day Form 4 window).
• Reported amounts/prices: 20,000 shares at $0.28/share = $5,660 (grant). Conversion of 20,000 derivative shares shown at $0.00.
• Shares owned after transaction: not specified in the provided filing excerpt.
• Footnotes: F1 notes the award of 20,000 shares under the Issuer's 2024 & 2025 Omnibus Incentive Plan (Rule 16b-3 exempt). F2 clarifies the RSUs were granted and vested on the grant date and are exempt under Rule 16b-3.

Context This was an equity award (RSUs) that vested on the grant date and converted into common stock — not an open-market purchase or sale. Awards that vest immediately increase insider stockholdings but are routine compensation events and are reported under Rule 16b-3 exemptions. The late filing reduces timeliness of the disclosure; it does not change the economic nature of the transaction but may be of interest to investors tracking insider activity.